Calcification Propensity in Serum and Cardiovascular Outcome in Peripheral Artery Disease

Marija Bojic1, Bernhard Bielesz1, Daniel Cejka2

  • 1Division of Nephrology, Medicine III, Medical University of Vienna, Austria.

Insights

The T50 test measures serum calcification propensity. Lower T50 values, indicating higher calcification propensity, are linked to major adverse cardiovascular events and cardiovascular mortality in peripheral artery disease patients.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Biochemistry

Background:

  • Peripheral artery disease (PAD) is associated with increased cardiovascular risk.
  • Serum calcification propensity, measured by the T50 test, is a novel biomarker linked to cardiovascular events and mortality in various populations.
  • The role of calcification propensity in PAD patients without severe chronic kidney disease (CKD) requires further investigation.

Purpose of the Study:

  • To investigate the association between serum calcification propensity (T50 test) and major adverse cardiovascular events (MACE+) and mortality in patients with PAD.
  • To assess the predictive value of T50 test for cardiovascular outcomes in a cohort of PAD patients without severe CKD.

Main Methods:

  • A cohort of 287 patients with PAD without severe CKD was studied.
  • Serum calcification propensity was measured using the T50 test.
  • Major cardiovascular events (MACE+) and all-cause death were evaluated over a median follow-up of 4 years, and long-term mortality over 8.7 years.
  • Kaplan-Meier and Cox regression analyses were used to assess associations, with adjustments for cardiovascular risk factors (CVRFs), PAD stage, and media sclerosis.

Main Results:

  • Mean T50 time was 268 ± 63 minutes.
  • Low T50 values (high calcification propensity) were significantly associated with MACE+ (HR: 0.72; 95% CI: 0.55-0.94), an association that persisted after multivariate adjustment (HR: 0.65; CI: 0.47-0.91).
  • Cardiovascular mortality was significantly associated with T50 after multivariate adjustment (HR: 0.72; CI: 0.53-0.99), but all-cause mortality was not.

Conclusions:

  • Serum calcification propensity, as measured by the T50 test, is associated with an increased risk of major adverse cardiovascular events in patients with PAD.
  • The T50 test may serve as a valuable prognostic biomarker for cardiovascular mortality in PAD patients.
  • These findings highlight the importance of assessing calcification propensity in PAD management.

Related Concept Videos

Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
70
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
157
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
64
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
86
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
479
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
81